AntineoplasticsHypersensitivity reactions: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1705卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47052-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[1] AntineoplasticsHypersensitivity reactions: 15 case reports
Reactions Weekly, 2016, 1583 (1) : 106 - 106
[2] AntineoplasticsHypersensitivity reactions: 4 case reports
Reactions Weekly, 2019, 1766 (1) : 40 - 40
[3] AntineoplasticsHypersensitivity reactions and anaphylaxis: 35 case reports
Reactions Weekly, 2022, 1934 (1) : 44 - 44
[4] AntineoplasticsHypersensitivity reaction: 11 case reports
Reactions Weekly, 2020, 1803 (1) : 35 - 35
[5] TozinameranNeurological reactions: 17 case reports
Reactions Weekly, 2022, 1937 (1) : 442 - 442
[6] AntineoplasticsHypersensitivity reaction, Aspergillus infection and fatal sepsis: 3 case reports
Reactions Weekly, 2019, 1734 (1) : 53 - 53
[7] Various drugsCutaneous adverse reactions: 17 case reports
Reactions Weekly, 2012, 1389 (1) : 41 - 41
[8] Various drugsIgE-mediated hypersensitivity reactions: 17 case reports
Reactions Weekly, 2015, 1547 (1) : 271 - 271
[9] Amoxicillin/antihypertensives/nonsteroidal anti inflammatoriesAnaphylactic reactions and worsening of anaphylactic reactions : 17 case reports
Reactions Weekly, 2019, 1765 (1) : 30 - 30
[10] AntineoplasticsHypersensitivity, thrombocytopenia and hepatitis: case report
Reactions Weekly, 2013, 1474 (1) : 8 - 8

← 1 2 3 4 5 →